(Q51107497)
Statements
A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer. (English)
1 reference
Dreicer R
1 reference
Kemp JD
1 reference
Stegink LD
1 reference
Cardillo T
1 reference
Davis CS
1 reference
Forest PK
1 reference
See WA
1 reference
1 January 1997
1 reference
15
1 reference
4
1 reference
311-317
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference